Propofol is an intravenous general anesthetic and sedative drug for use in the induction and maintenance of anesthesia or sedation. Hospira has voluntarily recalled 1 lot of Propofol Injectable ...

Induction of General Anesthesia for Patients Greater than or Equal to 3 Years of Age Maintenance of General Anesthesia for Patients Greater than or Equal to 2 Months of Age Initiation and Maintenance ...

(RTTNews) - Hospira, Inc., a Pfizer co., is recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol), due to the potential presence of visible particulates, the U.S. Food and Drug ...

Diprivan is a trademark of Fresenius Kabi USA, LLC. Dr. Reddy's Propofol Injectable Emulsion, USP is available in 10 mg/mL vials for Single Patient Use Only. Dr ...

Hospira and the FDA notified healthcare professionals of a nationwide recall of three lots of Propofol Injectable Emulsion 1% (1g/100mL), due to visible particles embedded in the glass to the user ...

* HIKMA - LAUNCH OF PROPOFOL INJECTABLE EMULSION, USP, 20 ML, 50 ML AND 100 ML VIALS, IN UNITED STATES * HIKMA - PROPOFOL INJECTABLE EMULSION IS CURRENTLY ON FDA'S DRUG SHORTAGE LIST, FOLLOWING A ...

Amneal has received the Food and Drug Administration’s permission for Propofol Injectable Emulsion, 200 mg/20 ml (10 mg/ml), 500 mg/50 ml (10 mg/ml) and 1,000 mg/100 mL (10 mg/ml), Single-Dose Vials.

Lake Forest, Ill.-based Hospira has voluntarily recalled seven lots of its Propofol Injectable Emulsion, USP, citing metal particulate embedded in the interior neck of the vial as well as ...

Propofol Injectable Emulsion is indicated for the initiation and maintenance of sedation and anesthesia, including for intubated, mechanically ventilated adults in the Intensive Care Unit. It is ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (“ANDA”) approval from ...